Regression of choroidal metastasis secondary to breast carcinoma with adjuvant intravitreal injection of bevacizumab.
Yao
Hsin-Yu
HY
Horng
Chi-Ting
CT
Chen
Jiann-Torng
JT
Tsai
Ming-Ling
ML
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D001943:Breast Neoplasms / Q000473:pathology*; D002277:Carcinoma / Q000188:drug therapy* / Q000556:secondary*; D002830:Choroid Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D005260:Female; D006801:Humans; D056965:Injections, Intraocular; D008875:Middle Aged; D016896:Treatment Outcome; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab